Video

Treatment Sequencing in LBCL: Clinical Trial and Real-World Data

Author(s):

Manali Kamdar, MDMatthew A. Lunning, DO, FACP

Experts discuss the role of clinical and real-world data in informing treatment sequencing in patients with large B-cell lymphoma (LBCL) in the academic and community setting,

Related Videos
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
Matthew Matasar, MD, chief, Division of Blood Disorders, Rutgers Cancer Institute; professor, medicine, Rutgers Robert Wood Johnson Medical School
Sattva S. Neelapu, MD
Sattva S. Neelapu, MD
Julie M. Vose, MD, MBA
Lakshmi Nayak, MD
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
Jakub Svoboda, MD
Video 6 - "Reflex Testing for Patients with Suspected Lung Cancer"
Related Content
Adam Kittai, MD, of The Ohio State University
June 16th 2024

CD19-Directed CAR T-Cell Therapy Demonstrates Clinical Efficacy in Richter Transformation

Matthew Lunning, DO, FACP
December 21st 2023

Lunning and Mehta-Shah Unpack Treatment Needs and Future Directions in PTCL

Radhika Bansal, MBBS
June 14th 2024

CAR T-Cell Therapy Is Safe, Feasible in Outpatient Setting for NHL

Matthew Lunning, DO, FACP
October 30th 2023

Lunning and Nastoupil Highlight Treatment Considerations and Ongoing Research in Follicular Lymphoma

Ibrahim T. Aldoss, MD
June 14th 2024

CD7-Directed CAR T-Cell Therapy WU-CART-007 Is Safe in R/R T-ALL/LBL

Marie Hu, MD
June 13th 2024

CAR T-Cell Therapy vs Bispecific Antibodies: Picking an Approach in R/R DLBCL